| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.13B | 70.75B | 73.14B | 64.31B | 55.17B | 55.01B |
| Gross Profit | 16.94B | 17.32B | 15.86B | 13.30B | 11.41B | 13.01B |
| EBITDA | 7.85B | 8.79B | 8.32B | 6.14B | 5.02B | 6.50B |
| Net Income | 4.87B | 5.65B | 5.10B | 3.63B | 2.75B | 3.86B |
Balance Sheet | ||||||
| Total Assets | 100.54B | 103.10B | 100.54B | 89.74B | 80.77B | 79.06B |
| Cash, Cash Equivalents and Short-Term Investments | 25.45B | 24.50B | 24.04B | 22.33B | 23.36B | 22.91B |
| Total Debt | 4.35B | 4.49B | 4.14B | 3.67B | 1.35B | 1.60B |
| Total Liabilities | 21.07B | 22.44B | 24.70B | 21.08B | 17.01B | 17.49B |
| Stockholders Equity | 76.26B | 77.28B | 72.82B | 65.89B | 61.41B | 59.37B |
Cash Flow | ||||||
| Free Cash Flow | 1.71B | 1.53B | 2.52B | -2.03B | 1.90B | 3.10B |
| Operating Cash Flow | 5.15B | 7.32B | 4.18B | 2.03B | 2.69B | 4.94B |
| Investing Cash Flow | -3.13B | -5.55B | -1.83B | -4.12B | -819.00M | -1.75B |
| Financing Cash Flow | -1.85B | -1.79B | -819.00M | 937.00M | -1.64B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥70.33B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
78 Outperform | ¥94.69B | 15.46 | 7.34% | 3.69% | 2.13% | -1.16% | |
75 Outperform | ¥110.06B | 19.34 | ― | 0.55% | 9.04% | -7.84% | |
75 Outperform | ¥64.75B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
74 Outperform | ¥43.40B | 6.65 | ― | 2.78% | 0.25% | -18.79% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥30.92B | 4.17 | ― | 2.13% | 1.13% | -66.14% |